Click image to zoom

Indian Economy

An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on August 8, 2025. President Donald Trump tells CNBC's ''Squawk Box'' on Tuesday that planned tariffs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he threatens so far. Meanwhile, in an escalation of trade tensions between the United States and India, US President Donald Trump, on August 6, 2025, signs an executive order imposing a 25 percent ad valorem tariff on all Indian imports into the United States. The ad valorem duty imposed in Executive Order 14257 applies in addition to the ad valorem duty imposed in section 2 of the order. This effectively means some categories of Indian exports may face a combined tariff burden of over 50 percent, depending on their classification. (Photo by Firdous Nazir/NurPhoto)

Photo ID	#12625477
Date Taken	8 August 2025
Location	N/A
Photographer	Firdous Nazir/NurPhoto
Category	Economy, Business and Finance
Copyright	© 2026 NurPhoto - Firdous Nazir/NurPhoto

employee stock medicines pharmacy Srinagar Jammu and Kashmir August 08 2025 President Donald Trump CNBC Squawk Box tariffs pharmaceuticals imported U.S. 250% highest rate threatened trade tensions United States India executive order 25 percent ad valorem tariff Indian imports Executive Order 14257 section 2 combined tariff burden over 50 percent classification Firdous Nazir NurPhoto August 06 2025 escalation trade duty.